UNIVERSITY OF SOUTH FLORIDA
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1956-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.usf.edu
NeuroEM Therapeutics Secures $1.33 Million in Series A Funding to Advance Drug-Free Alzheimer's Treatment
NeuroEM Therapeutics has closed initial rounds totaling $1.33 million of a $5 million Series A equity raise led by BlueLake.vc to commercialize its Transcranial Electromagnetic Treatment (TEMT-RF) technology.
Amneal's CREXONT Shows Significant Sleep Quality Improvements in Parkinson's Disease Patients
New Phase 3 RISE-PD study data reveals CREXONT (carbidopa/levodopa extended-release) significantly improved sleep quality in Parkinson's disease patients compared to immediate-release formulations, with a mean difference of -2.35 in PDSS-2 scores (p<0.0001).
Dupilumab Shows Strong Efficacy in Chronic Spontaneous Urticaria Across All BMI Ranges
Phase 3 LIBERTY-CSU CUPID trials demonstrate dupilumab's effectiveness in reducing itch and urticaria activity in patients unresponsive to H1-antihistamines.
North American Hospitals Spearhead Clinical Trials for Trigeminal Neuralgia
Leading hospitals across North America are actively engaged in clinical trials to find effective treatments for trigeminal neuralgia, a condition causing severe facial pain.